Elder Pharma rises on plans to foray into lifestyle healthcare sector

31 Oct 2011 Evaluate

Elder Pharmaceuticals is currently trading at Rs. 387.00, up by 4.50 points or 1.18% from its previous closing of Rs. 382.50 on the BSE.

The scrip opened at Rs. 389.90 and has touched a high and low of Rs. 389.90 and Rs. 385.10 respectively. So far 19,358 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 435.00 on 21-Oct-2010 and a 52 week low of Rs. 309.20 on 25-Nov-2010.

Last one week high and low of the scrip stood at Rs. 394.00 and Rs. 379.00 respectively. The current market cap of the company is Rs. 794.00 crore.

The promoters holding in the company stood at 38.46% while Institutions and Non-Institutions held 28.64% and 32.90% respectively.

Drug firm, Elder Pharmaceuticals is planning to increase its market share by foraying into the growing personal and lifestyle healthcare sector including hypertension, diabetes and cardiac care. The pharma major’s main strength is marketing the women's healthcare product - Shelcal which is a calcium supplement used to prevent osteoporosis, and its extensions.

The company has recently added manufacturing plant in New Bombay, pursuant to which it has acquired a strong presence in women's healthcare, nutraceuticals, anti-infectives, lifestyle diseases and pain management.

Elder Pharmaceuticals (EPL) is engaged in the manufacturing and marketing of mainly pharmaceutical formulations, under its own as well as in-licensed brands, and offers a gamut of products in the Active Pharmaceutical Ingredients (API)/bulk drugs. The company is also a distributor of the cosmeceutical products.

Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×